Effectiveness of Abhaya-Nagara Churna and Vasavaleha in Tamaka Swasa(Bronchial Asthma).

A comparative study to evaluate the effectiveness of Abhaya-Nagara Churna and Vasavaleha in management of Tamaka Swasa(Bronchial Asthma).

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/04/042167

Enrollment

Registered

2022-04-26

Start date

Unknown

Completion date

Unknown

Last updated

2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J454- Moderate persistent asthma

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients between 18-60 years of age, irrespective of gender, cast, and religion will be included. 2. Patients with mild and moderate cardinal symptoms (according to GINA). 3. Patients who had a history of recurrent symptoms for more than 6 months. 4. Subjects who are ready to give consent for trial with firm residential address and contact numbers.

Exclusion criteria

Exclusion criteria: 1. Patients below 18 years of age and above 60 years of age. 2. Asthmatics having severe attack (according to GINA). 3. Patients with other systemic disorders. 4. Other complicated respiratory disorders like COPD, bronchiectasis, TB, etc. 5. Pregnant women and lactating mother. 6. Patients addicted to smoking. 7. Subjects with known hypersensitivity to any of the contents of Abhaya Nagara churna or Vasavaleha. 8. Patients having asthma like symptoms due some allergic reaction to any food or drug.

Design outcomes

Primary

Measure	Time frame
ACT(Asthma Control Test)Timepoint: DAY 1, 7, 14, 28	—

Secondary

Measure	Time frame
Absolute Eosinophill Count (AEC)Timepoint: Day 1, 7, 14, 28;Asthma Quality of Life Questionnaire(AQLQ) scoreTimepoint: Day 1, 7, 14, 28;Erythrocyte Sedimentation Rate (ESR)Timepoint: Day 1, 7, 14, 28;Forced Expiratory Volume in 1 second (FEV1)Timepoint: Day1 , 7, 14, 28;Improvement in Symptom Severity Grade of Tamaka SwasaTimepoint: Day 1, 7, 14 ,28	—

Countries

India

Contacts

Public ContactDr Pariksha Sharma

Chaudhary Brahm Prakash Ayurved Charak Sansthan

pariksha21sharma@gmail.com9654497757

Outcome results